annual current liabilities:
$1.13B+$283.18M(+33.45%)Summary
- As of today (August 16, 2025), AMRX annual total current liabilities is $1.13 billion, with the most recent change of +$283.18 million (+33.45%) on December 31, 2024.
- During the last 3 years, AMRX annual current liabilities has risen by +$452.53 million (+66.82%).
- AMRX annual current liabilities is now at all-time high.
Performance
AMRX Current liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly current liabilities:
$1.11B+$31.31M(+2.91%)Summary
- As of today (August 16, 2025), AMRX quarterly total current liabilities is $1.11 billion, with the most recent change of +$31.31 million (+2.91%) on June 30, 2025.
- Over the past year, AMRX quarterly current liabilities has dropped by -$7.22 million (-0.65%).
- AMRX quarterly current liabilities is now -2.00% below its all-time high of $1.13 billion, reached on December 31, 2024.
Performance
AMRX quarterly current liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Current liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
AMRX Current liabilities Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +33.5% | -0.7% |
3 y3 years | +66.8% | +11.5% |
5 y5 years | +105.3% | +69.0% |
AMRX Current liabilities Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +66.8% | -2.0% | +57.3% |
5 y | 5-year | at high | +105.3% | -2.0% | +83.9% |
alltime | all time | at high | >+9999.0% | -2.0% | +272.9% |
AMRX Current liabilities History
Date | Annual | Quarterly |
---|---|---|
Jun 2025 | - | $1.11B(+2.9%) |
Mar 2025 | - | $1.08B(-4.8%) |
Dec 2024 | $1.13B(+33.4%) | $1.13B(+3.2%) |
Sep 2024 | - | $1.10B(-1.7%) |
Jun 2024 | - | $1.11B(+33.6%) |
Mar 2024 | - | $834.39M(-1.4%) |
Dec 2023 | $846.60M(+12.5%) | $846.60M(+11.3%) |
Sep 2023 | - | $760.60M(-2.2%) |
Jun 2023 | - | $777.35M(+10.5%) |
Mar 2023 | - | $703.71M(-6.5%) |
Dec 2022 | $752.80M(+11.2%) | $752.80M(-8.0%) |
Sep 2022 | - | $818.00M(-17.6%) |
Jun 2022 | - | $993.06M(+64.9%) |
Mar 2022 | - | $602.04M(-11.1%) |
Dec 2021 | $677.24M(+0.1%) | $677.24M(+1.5%) |
Sep 2021 | - | $667.34M(-0.8%) |
Jun 2021 | - | $672.86M(+5.7%) |
Mar 2021 | - | $636.78M(-5.9%) |
Dec 2020 | $676.90M(+23.0%) | $676.90M(+1.3%) |
Sep 2020 | - | $667.89M(+2.0%) |
Jun 2020 | - | $655.02M(-32.1%) |
Mar 2020 | - | $965.07M(+75.3%) |
Dec 2019 | $550.41M | $550.41M(+2.9%) |
Sep 2019 | - | $534.91M(-2.1%) |
Date | Annual | Quarterly |
---|---|---|
Jun 2019 | - | $546.16M(-8.9%) |
Mar 2019 | - | $599.53M(+8.2%) |
Dec 2018 | $553.85M(+86.6%) | $553.85M(-26.1%) |
Sep 2018 | - | $749.27M(+11.9%) |
Jun 2018 | - | $669.74M(+125.6%) |
Dec 2017 | $296.88M(-7.6%) | $296.88M |
Dec 2016 | $321.32M(-1.7%) | - |
Dec 2015 | $326.76M(+105.9%) | - |
Dec 2014 | $158.70M(+3.1%) | - |
Dec 2013 | $153.89M(+5.9%) | - |
Dec 2012 | $145.29M(-7.4%) | - |
Dec 2011 | $156.86M(+24.1%) | - |
Dec 2010 | $126.42M(-38.0%) | - |
Dec 2009 | $203.87M(+85.6%) | - |
Dec 2008 | $109.83M(-31.5%) | - |
Dec 2007 | $160.35M(+62.4%) | - |
Dec 2006 | $98.75M(+35.1%) | - |
Dec 2005 | $73.08M(+72.5%) | - |
Dec 2003 | $42.37M(+82.2%) | - |
Dec 2002 | $23.25M(+197.9%) | - |
Dec 2001 | $7.80M(+19.9%) | - |
Dec 2000 | $6.51M(-12.3%) | - |
Dec 1999 | $7.42M(+154.8%) | - |
Dec 1998 | $2.91M | - |
FAQ
- What is Amneal Pharmaceuticals, Inc. annual total current liabilities?
- What is the all time high annual current liabilities for Amneal Pharmaceuticals, Inc.?
- What is Amneal Pharmaceuticals, Inc. annual current liabilities year-on-year change?
- What is Amneal Pharmaceuticals, Inc. quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Amneal Pharmaceuticals, Inc.?
- What is Amneal Pharmaceuticals, Inc. quarterly current liabilities year-on-year change?
What is Amneal Pharmaceuticals, Inc. annual total current liabilities?
The current annual current liabilities of AMRX is $1.13B
What is the all time high annual current liabilities for Amneal Pharmaceuticals, Inc.?
Amneal Pharmaceuticals, Inc. all-time high annual total current liabilities is $1.13B
What is Amneal Pharmaceuticals, Inc. annual current liabilities year-on-year change?
Over the past year, AMRX annual total current liabilities has changed by +$283.18M (+33.45%)
What is Amneal Pharmaceuticals, Inc. quarterly total current liabilities?
The current quarterly current liabilities of AMRX is $1.11B
What is the all time high quarterly current liabilities for Amneal Pharmaceuticals, Inc.?
Amneal Pharmaceuticals, Inc. all-time high quarterly total current liabilities is $1.13B
What is Amneal Pharmaceuticals, Inc. quarterly current liabilities year-on-year change?
Over the past year, AMRX quarterly total current liabilities has changed by -$7.22M (-0.65%)